LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial

Journal:

Nature Communications

Published:

2026-02-16

DOI:

10.1038/s41467-026-69629-0

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
Science for Life Laboratory (SciLifeLab), Sweden	4.500000	0.30
Lokon Pharma AB, Sweden	4.000000	0.27
The Angeles Clinic and Research Institute, United States of America (USA)	2.000000	0.13
Baylor College of Medicine (BCM), United States of America (USA)	2.000000	0.13
Uppsala University Hospital, Sweden	1.500000	0.10
Uppsala University (UU), Sweden	1.000000	0.07

Interested in Oncology and Carcinogenesis?